Association between triglyceride-glucose index and all-cause mortality in non-diabetic patients with fibrotic lung disease receiving antifibrotic therapy: A retrospective cohort study
Aysegul Erinc, Ali Kirac, Fatma Ezgi Altun Acar, Abdullah Cagri Onal, Erdogan Cetinkaya · 2026
Read Association between triglyceride-glucose index and all-cause mortality in non-diabetic patients with fibrotic lung disease receiving antifibrotic therapy: A retrospective cohort study by Aysegul Erinc, Ali Kirac, Fatma Ezgi Altun Acar, Abdullah Cagri Onal, Erdogan Cetinkaya (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0357706.txt.
Description
Aysegul Erinc and colleagues ask whether a simple blood score predicts survival in people with scarring lung disease who do not have diabetes. The score combines fasting sugar and blood fat values and is often read as a sign of insulin resistance. Records covered well over a hundred patients on anti-scarring therapy, followed for close to three years on median, with lung tests and survival tracked.
The abstract reports the cohort's profile and the study design in detail, linking the score with lung function and death from any cause. Because patients here stayed within the non-diabetic range, the work tests whether small shifts in the score still carry meaning. Erinc and colleagues frame the score as a cheap add-on to scans and lung tests when judging outlook.
Catalog record
| CREATOR | Aysegul Erinc, Ali Kirac, Fatma Ezgi Altun Acar, Abdullah Cagri Onal, Erdogan Cetinkaya |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36652 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |